PDL BioPharma Inc. Reports 7% Increase In Q1 Bottom Line

(RTTNews) - PDL BioPharma Inc. (PDLI) revealed earnings for its first quarter that climbed from last year.

The company said its bottom line totaled $84.79 million, or $0.52 per share. This was up from $79.46 million, or $0.47 per share, in last year's first quarter.

The company said revenue for the quarter fell 31.1% to $103.12 million. This was down from $149.71 million last year.

PDL BioPharma Inc. earnings at a glance:

-Earnings (Q1): $84.79 Mln. vs. $79.46 Mln. last year. -Earnings Growth (Y-o-Y): 6.7% -EPS (Q1): $0.52 vs. $0.47 last year. -EPS Growth (Y-o-Y): 10.6% -Revenue (Q1): $103.12 Mln vs. $149.71 Mln last year. -Revenue Change (Y-o-Y): -31.1%